Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760899 · ClinicalTrials.gov registry record · NA
Cerebellar TDCS for SRPCS Treatment
A NA study of Post-Concussion Syndrome, sponsored by University of Iowa.
- Active
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04760899: Active NA study of Post-Concussion Syndrome, sponsored by University of Iowa.
NCT04760899 is a NA study of Post-Concussion Syndrome that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 31 participants, below the 58-participant average among 14 other Post-Concussion Syndrome trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04760899, a NA study of Post-Concussion Syndrome, is active but no longer recruiting, sponsored by University of Iowa.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating the immediate and long-term effects of bilateral cerebellar transcranial direct current stimulation on cognition, balance, and symptom severity in people with sports-related post-concussion syndrome. The central hypothesis is that tDCS will provide improvements in cognitive deficits, balance, and overall symptom attenuation in people with SRPCS both acutely and at 2 and 4 week follow ups. The researchers further hypothesize that cerebellar tDCS will ameliorate the symptoms of people with SRPCS.
Primary Outcome
Balance Assessment. This is a 14 item test with scores from 0 to 4, with 4 being no inhibition at all. The max score on this test is 56, higher scores indicating better balance.
Conditions Studied
Interventions
- DEVICE Transcranial Direct Current Stimulation
Study Locations (1)
Iowa
- Thorsten of Rudroff - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2027-07 |
| Phase | NA |
What the registry record for NCT04760899 still lists
NCT04760899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 58-participant average among 14 other Post-Concussion Syndrome trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Post-Concussion Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.
NCT04760899 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT04760899 about?
NCT04760899 is a clinical study titled "Cerebellar TDCS for SRPCS Treatment". This study is investigating the immediate and long-term effects of bilateral cerebellar transcranial direct current stimulation on cognition, balance, and symptom severity in people with sports-related post-concussion syndrome. The central hypothesis is that tDCS will provide improvements in cogniti...
What is the current status of trial NCT04760899?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2021-03-01. Estimated completion is 2027-07.
What conditions does trial NCT04760899 study?
This clinical trial studies the following conditions: Post-Concussion Syndrome.
What interventions are being tested in trial NCT04760899?
The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04760899?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04760899 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Concussion Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04760899's enrollment target sits among peer trials
31 9th of 14 higher than 6 of 14 other Post-Concussion Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Concussion Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Post-concussion Syndrome and Chiropractic
RECRUITING · NA
-
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
RECRUITING · NA
-
Mobile Subthreshold Exercise Program for Concussion--R01
ACTIVE NOT RECRUITING · NA
-
Brain Stimulation for Concussion
ACTIVE NOT RECRUITING · NA
-
Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI